Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

5.9K
5.9K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

11.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.7K
Cancer Prevention02:59

Cancer Prevention

8.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.6K
The Ras Gene02:38

The Ras Gene

2.4K
2.4K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

63
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
63
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

10.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First-Line Enfortumab Vedotin Plus Pembrolizumab vs Gemcitabine Plus Cisplatin for Metastatic Urothelial Carcinoma.

JAMA network open·2026
Same author

Kidney Morbidity in Pediatric Patients With Spina Bifida.

JAMA network open·2026
Same author

Letter: Urology Publication Output in Potentially Predatory Journals from 2019 to 2024.

The Journal of urology·2026
Same author

Forecasting Trends in Androgen Deprivation Therapy Intensification for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Population-Based Cohort and Time-Series Analysis.

Current oncology (Toronto, Ont.)·2026
Same author

Editorial Comment.

The Journal of urology·2026
Same author

Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

European urology·2026

Related Experiment Video

Updated: Mar 14, 2026

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

9.2K

Prostate Cancer Genetics: A Review.

Christopher J D Wallis1, Robert K Nam1

  • 1Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto , Toronto, Ontario, Canada.

EJIFCC
|September 30, 2016
PubMed
Summary

Identifying genetic changes like SCNAs and SNPs in prostate cancer aids early detection and personalized therapies. Understanding these genetic alterations is key for developing targeted treatments and improving patient outcomes.

Keywords:
DNA copy number variationschromosome abnormalitiesgenetic predispositionmicroRNAspoint mutationpolymorphismprostate cancersingle nucleotide

More Related Videos

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.9K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.3K

Related Experiment Videos

Last Updated: Mar 14, 2026

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

9.2K
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.9K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.3K

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Prostate cancer research has increasingly focused on its genetic basis.
  • Genetic and epigenetic changes significantly influence prostate cancer development and risk.
  • Somatic copy number alterations (SCNAs), mutations, and microRNAs (miRNAs) are implicated.

Purpose of the Study:

  • To review the role of various genetic alterations in prostate cancer.
  • To highlight the potential of genetic changes as biomarkers for early detection and risk stratification.
  • To emphasize the link between genetic understanding and personalized medicine approaches.

Main Methods:

  • Review of existing literature on genetic alterations in prostate cancer.
  • Analysis of the roles of SCNAs, structural rearrangements, point mutations, SNPs, and miRNAs.
  • Discussion of the implications for biomarker development and targeted therapies.

Main Results:

  • Various genetic changes, including SCNAs and SNPs, are associated with prostate cancer.
  • These genetic alterations can serve as predictive biomarkers for disease development.
  • Understanding these changes is crucial for patient risk stratification.
  • Genetic insights pave the way for personalized treatment strategies.

Conclusions:

  • Identifying genetic underpinnings of prostate cancer is vital for advancing diagnostics.
  • Novel biomarkers can be developed from genetic alterations for early detection and risk assessment.
  • A deeper understanding of genetic pathways supports the development of targeted therapies for personalized medicine.